Safety of Deucravacitinib in Asian Patients
Dr. Ron Vender reviews the safety of deucravacitinib in Asian patients at WCD2023 in Singapore.
top of page
Jeremy Visser
- Jul 14
- 1 min
PASI Reductions for an Oral TYK2 Inhibitor
Dr. Ron Vender reviews a poster about deucravacitinib.
Jeremy Visser
- Jul 13
- 1 min
Long Term Efficacy of Deucravacitinib
Dr. Ron Vender reviews the TYK2 inhibitor deucravacitinib at WCD2023 in Singapore.
Jeremy Visser
- Jul 13
- 1 min
Oral and Topical JAK Inhibitors
Dr. Ron Vender discusses JAK and TYK2 inhibitors at WCD2023 in Singapore.
Jeremy Visser
- Jul 12
- 1 min
VIDEO: Study shows lower fertility rates in patients with moderate-to-severe plaque psoriasis
Patients with moderate-to-severe plaque psoriasis have lower fertility rates and higher risk of pregnancy loss than women with psoriasis.
Jeremy Visser
- Jul 12
- 1 min
Phase II Trial for an Oral Peptide to Treat Plaque Psoriasis
Dr. Ron Vender discusses the late breaking study of an oral peptide to treat moderate-to-severe psoriasis at WCD2023 in Singapore.
Jeremy Visser
- Jul 12
- 1 min
Digital Dermatology and Artificial Intelligence
Dr. Ron Vender summarizes a presentation about AI and digital dermatology at WCD2023 in Singapore.
Jeremy Visser
- Jul 11
- 1 min
Speakers from the International Psoriasis Council
Dr. Ron Vender reviews critical IPC presentations from WCD2023 in Singapore.
Featured Posts
bottom of page